Moneycontrol
Moneycontrol PRO
Get App Open
In App
News on WhatsApp
News on WhatsApp
Go PRO Now
Open App
MARKETS

Strides Pharma Science Ltd.

BSE: 532531 | NSE: STAR |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE939A01011 | SECTOR: Pharmaceuticals & Drugs

| BSE 874.05 6.05 (0.70%) | |

BSE Live

Feb 23, 12:20
874.05 6.05 (0.70%)
Volume
AVERAGE VOLUME
5-Day
4,293
10-Day
5,267
30-Day
25,495
1,266

  • Prev. Close

    868.00

  • Open Price

    852.30

  • Bid Price (Qty.)

    874.05 (12)

  • Offer Price (Qty.)

    875.60 (26)

NSE Live

Feb 23, 12:20
874.80 5.15 (0.59%)
Volume
AVERAGE VOLUME
5-Day
211,989
10-Day
215,935
30-Day
495,607
66,323

  • Prev. Close

    869.65

  • Open Price

    878.00

  • Bid Price (Qty.)

    874.65 (42)

  • Offer Price (Qty.)

    874.80 (113)

Financials

Cash Flow of Strides Pharma Science (in Rs. Cr.) Mar 15 Mar 14 Dec 12 Dec 11 Dec 10  
  12 mths 15 mths 12 mths 12 mths 12 mths  
Net Profit/Loss Before Extraordinary Items And Tax 148.58 2,889.87 949.49 272.69 186.38  
Net CashFlow From Operating Activities 83.40 -271.68 134.36 457.10 323.93  
Net Cash Used In Investing Activities 51.87 4,077.09 806.54 -656.47 -941.00  
Net Cash Used From Financing Activities -421.25 -3,318.53 -990.03 89.36 850.10  
Foreign Exchange Gains / Losses -1.61 -1.32 4.50 -3.34 0.00  
Adjustments On Amalgamation Merger Demerger Others 0.00 -31.59 -35.17 0.45 0.00  
Net Inc/Dec In Cash And Cash Equivalents -287.59 453.98 -79.80 -112.90 233.03  
Cash And Cash Equivalents Begin of Year 586.01 132.02 212.27 325.17 91.93  
Cash And Cash Equivalents End Of Year 298.42 586.01 132.47 212.27 324.96  
Source : Dion Global Solutions Limited

Results of Strides Pharma

Results of Pharmaceuticals Sector

Quick links

News

Corporate Action

Information

Financials

Annual Report

Peer Comparison

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
Close Parallel Income Plan 2026